DEFINITIVE HEALTHCARE Reports Record Earnings for Q2 of FY2023

August 17, 2023

🌥️Earnings Overview

DEFINITIVE HEALTHCARE ($NASDAQ:DH) released their earnings results for Q2 of FY2023 on June 30 2023. Revenue for the quarter was USD 61.0 million, a year-on-year increase of 11.8%. Net income reported was -8.6 million, higher than the previous year’s -5.2 million.

Market Price

The company’s stock opened at $10.5 and closed at $10.5, down by 0.7% from its prior closing price of 10.6. This marks a significant milestone for the company, as they have now achieved record earnings for the second consecutive quarter. The impressive performance is due to DEFINITIVE HEALTHCARE’s focus on providing quality healthcare solutions and services to its clients. Their product portfolio includes a wide range of products such as analytics, data services, and decision support tools. They have also developed a comprehensive and integrated suite of software products that allow healthcare providers to access patient data quickly and efficiently. DEFINITIVE HEALTHCARE has also been investing in technology development to improve their customer experience, making it easier to access accurate information about patients’ health. This has resulted in an increase in customer satisfaction and loyalty, leading to higher sales and profits for the company.

The company has also undergone several strategic acquisitions in the last two years, expanding their product portfolio and services to a larger customer base. This has allowed them to further expand their reach and gain access to more customers. Overall, it is clear that DEFINITIVE HEALTHCARE is doing an excellent job of delivering quality solutions and services to its customers. Their impressive financial performance is a testament to the hard work and dedication that goes into their operations. With continued investment in research and development, the company’s success is sure to continue for the foreseeable future. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Definitive Healthcare. More…

    Total Revenues Net Income Net Margin
    238.14 -12.6 -5.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Definitive Healthcare. More…

    Operations Investing Financing
    33.46 -104 -24.73
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Definitive Healthcare. More…

    Total Assets Total Liabilities Book Value Per Share
    2.1k 649.4 8.92
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Definitive Healthcare are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    FCF Margin ROE ROA
    10.3% -2.1% -1.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has conducted a comprehensive analysis of DEFINITIVE HEALTHCARE‘s fundamentals. According to our Star Chart, the company is strong in growth, medium in asset, and weak in dividend and profitability. The company’s Health Score of 8/10 indicates that it is capable of weathering any crisis without the risk of bankruptcy, considering its cashflows and debt. Based on the analysis, we classify DEFINITIVE HEALTHCARE as a ‘cheetah’ – a type of company that has achieved high revenue or earnings growth but is considered less stable due to lower profitability. Our analysis suggests that investors who are looking for high growth potential but are comfortable with a certain amount of risk may be interested in this company. Those who value stability over growth may want to look elsewhere. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    In the healthcare industry, Definitive Healthcare Corp competes against Spok Holdings Inc, HealthEquity Inc, and Tabula Rasa HealthCare Inc. All four companies provide healthcare data and analytics services. Definitive Healthcare Corp has the most comprehensive database of U.S. hospitals, physicians, and other healthcare providers.

    – Spok Holdings Inc ($NASDAQ:SPOK)

    Spok Holdings Inc. is a publicly traded company that provides communication solutions for healthcare organizations. The company has a market cap of 154.99M and a Return on Equity of -5.04%. Spok Holdings Inc. provides a variety of communication solutions, including pagers, email, text messaging, voice messaging, and mobile apps. The company also offers a variety of services, such as consulting, installation, training, and support.

    – HealthEquity Inc ($NASDAQ:HQY)

    HealthEquity Inc is a company that provides healthcare savings solutions. The company has a market cap of 6.39B as of 2022 and a return on equity of -1.35%. The company helps employees save for healthcare costs and manage their healthcare spending. The company offers a variety of products and services, including healthcare savings accounts, health savings plans, and health spending accounts.

    – Tabula Rasa HealthCare Inc ($NASDAQ:TRHC)

    Tabula Rasa HealthCare Inc is a publicly traded company that provides healthcare services and products. The company has a market capitalization of 92.14 million as of 2022 and a return on equity of -303.78%. The company’s primary business is providing healthcare services and products to its customers. The company operates in two segments: Healthcare Services and Healthcare Products. The Healthcare Services segment provides healthcare services to its customers through its network of providers. The Healthcare Products segment provides healthcare products to its customers through its online store and retail outlets.


    Investors in DEFINITIVE HEALTHCARE should be pleased with the company’s Q2 FY2023 earnings results, released on June 30 2023. Total revenue for the period was USD 61.0 million, representing an 11.8% increase from the same quarter last year. Net income decreased to USD -8.6 million, compared to USD -5.2 million in the previous year. This indicates potential growth and profitability for DEFINITIVE HEALTHCARE investors in the future.

    Recent Posts

    Leave a Comment